Previous 10 | Next 10 |
Gainers: Triple-S Management (NYSE:GTS) +45%, Bio-Path (NASDAQ:BPTH) +21%, Reviva Pharmaceuticals (NASDAQ:RVPH) +21%, XTL Biopharmaceuticals (NASDAQ:XTLB) +13%, Protara Therapeutics (NASDAQ:TARA) +12%. Losers: Theravance Biopharma (NASDAQ:TBPH) ...
-Closed Underwritten Public Offering of Common Stock and Warrants Resulting in Gross Proceeds of $34.5 Million -Expected to Initiate Pivotal Phase 3 Clinical Trial in Schizophrenia in Q4’21 -$35.8 Million in Cash as of June 30, 2021 CUPERTINO, Calif., Aug. 1...
Gainers: Tyme Technologies TYME +46%, Xenetic Biosciences XBIO +40%, IMV (IMV) +18%, Translate Bio (TBIO) +10%, Reviva Pharmaceuticals (RVPH) +9%.Losers: ATI Physical Therapy ATIP -40%, Iterum Therapeutics ITRM -36%, Intec Pharm...
CUPERTINO, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (along with its subsidiaries, “Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical nee...
Anaplan (PLAN) -16% on Q1 earnings releaseEZGO Technologies (EZGO) -11%.Kintara Therapeutics (KTRA) -8%.Reviva Pharmaceuticals Holdings (RVPH) -10% after raises $30M capital via stock offeringLizhi (LIZI) -7%.Protagenic Therapeutics (PTIX) -7%.Dollar Tree (DLTR) -7%...
Reviva Pharmaceuticals (RVPH) has priced its public offering of 8M common shares (or pre-funded warrants to purchase common stock) and accompanying investor warrants to purchase up to 6M shares of common stock.Each common share/pre-funded warrant is being sold together with one investor ...
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central ner...
Gainers: Tian Ruixiang (TIRX) +54%.Vaxart (VXRT) +51%.RiceBran Technologies (RIBT) +47%.Aldeyra Therapeutics (ALDX) +31%.NetSol Technologies (NTWK) +30%.First Choice Bancorp (FCBP) +28%.TrueBlue (TBI) +26%.Brooklyn ImmunoTherapeutics (BTX) +23%.Big Rock Partners Acquisition (BRPA) +23%.T...
InspireMD (NSPR) -19%.Reviva Pharmaceuticals (RVPH) -17%.RealNetworks RNWK -16% on preliminary estimates for its first-quarter, stock offering.Mechanical Technology (MKTY) -10% after subsidiary announces newest addition of the PBS-4100+ portable vibration and balancing system.S...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Reviva Pharmaceuticals (NASDAQ: RVPH ) and RVPH stock are seeing explosive gains of more than 90% at the time of writing. Source: Shutterstock Today’s move nearly doub...
News, Short Squeeze, Breakout and More Instantly...
Reviva Pharmaceuticals Holdings Inc. Company Name:
RVPH Stock Symbol:
NASDAQ Market:
Reviva Pharmaceuticals Holdings Inc. Website:
- Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD) -Similar patents have also been granted in k...
2024-06-11 08:15:03 ET H.C. Wainwright analyst issues BUY recommendation for RVPH on June 11, 2024 06:40AM ET. The previous analyst recommendation was Buy. RVPH was trading at $1.45 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ...
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous ...